NO934547L - Oral treatment of Helicobacter infection - Google Patents
Oral treatment of Helicobacter infectionInfo
- Publication number
- NO934547L NO934547L NO934547A NO934547A NO934547L NO 934547 L NO934547 L NO 934547L NO 934547 A NO934547 A NO 934547A NO 934547 A NO934547 A NO 934547A NO 934547 L NO934547 L NO 934547L
- Authority
- NO
- Norway
- Prior art keywords
- oral treatment
- helicobacter infection
- helicobacter
- infection
- host
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Fremgangsmåte for å frembringe en beskyttende immunrespons mot Helicobacter-infeksjon i en pattedyrvert, ved at det til verten administreres oralt en immunogenisk effektiv mengde Helicobacter-antigen. Vaksinepreparater er også beskrevet.A method of producing a protective immune response to Helicobacter infection in a mammalian host by administering orally to the host an immunogenically effective amount of Helicobacter antigen. Vaccine preparations are also disclosed.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86828692A | 1992-04-13 | 1992-04-13 | |
PCT/US1993/003409 WO1993020843A1 (en) | 1992-04-13 | 1993-04-09 | Oral treatment of helicobacter infection |
Publications (1)
Publication Number | Publication Date |
---|---|
NO934547L true NO934547L (en) | 1994-02-10 |
Family
ID=26786672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO934547A NO934547L (en) | 1992-04-13 | 1993-12-10 | Oral treatment of Helicobacter infection |
Country Status (1)
Country | Link |
---|---|
NO (1) | NO934547L (en) |
-
1993
- 1993-12-10 NO NO934547A patent/NO934547L/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1170016A3 (en) | Urease-based vaccine against helicobacter infection | |
MX9301706A (en) | VACCINE COMPOSITION FOR THE TREATMENT OF HELICOBACTER INFECTION. | |
RU93058676A (en) | ORAL TREATMENT OF HELICOBACTERIAL INFECTION | |
CA2033640A1 (en) | Vaccines against cancer and infectious diseases | |
NO950483L (en) | Hepatitis A vaccine | |
ATE244578T1 (en) | TREATMENT OF GASTRODUODENAL DISEASE CAUSED BY HELICOBACTER | |
NO974727L (en) | Immunogenic and immunostimulatory oligosaccharide compositions and methods for their preparation | |
NO934547L (en) | Oral treatment of Helicobacter infection | |
FI932759A0 (en) | Enhancement of IL-4 For the purpose of vaccinia immunogenic generic immunoreaction | |
FR2646776B1 (en) | USE OF VACCINANT PREPARATIONS BASED ON ADENYL CYCLASE OR OF BACTERIA PRODUCING THEM AS PROTECTIVE ANTIGENS AGAINST THE EFFECTS OF BORDETELLA | |
EP0328390A3 (en) | Peptide treatment of refractory infectious diseases | |
AU8501191A (en) | Cross-reactive influenza a immunization | |
ATE206138T1 (en) | HELICOBACTER PYLORI ANTIGEN | |
NO980721L (en) | vaccinations | |
NO931821L (en) | Hepatitis B Vaccine Preparation Containing A Bile Acid Salt | |
JPS562918A (en) | Preventive and remedy for infection of pig atrophic rhinitis | |
NO930820L (en) | PATHOGEN-SPECIFIC CTL THERAPY |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |